Summary
=======

An 84-year-old man presented 5 years after bioprosthetic mitral valve replacement with three months of worsening dyspnea on exertion. A new mitral stenosis murmur was noted on physical examination, and an electrocardiogram revealed newly recognized atrial fibrillation. Severe mitral stenosis (mean gradient = 13 mmHg) was confirmed by transthoracic echocardiography. Transesophageal echocardiography revealed markedly thickened mitral bioprosthetic leaflets with limited mobility, and a massive left atrial thrombus (\>4 cm in diameter) ([Fig. 1A](#fig1){ref-type="fig"}, [B](#fig1){ref-type="fig"},[C](#fig1){ref-type="fig"}, [D](#fig1){ref-type="fig"} and [Videos 1](#SM1){ref-type="supplementary-material"}, [2](#SM2){ref-type="supplementary-material"}, [3](#SM3){ref-type="supplementary-material"} and [4](#SM4){ref-type="supplementary-material"}). Intravenous heparin was initiated, and 5 days later, he was taken to the operating room for planned redo mitral valve replacement and left atrial thrombus extraction. Intraoperative transesophageal echocardiography revealed near-complete resolution of the bioprosthetic leaflet thickening, and a mean mitral gradient of only 3 mmHg ([Fig. 2A](#fig2){ref-type="fig"}, [B](#fig2){ref-type="fig"}, [C](#fig2){ref-type="fig"} and [Videos 5](#SM5){ref-type="supplementary-material"}, [6](#SM6){ref-type="supplementary-material"} and [7](#SM7){ref-type="supplementary-material"}). The patient underwent resection of the massive left atrial thrombus ([Fig. 2D](#fig2){ref-type="fig"}) but did not require redo mitral valve replacement. He was initiated on heparin (and transitioned to warfarin) early in the post-operative period, with complete resolution of dyspnea on exertion at 3-month follow-up. Bioprosthetic valve thrombosis is increasingly recognized as a cause of early prosthetic valve dysfunction ([@bib1], [@bib2]). This case illustrates that bioprosthetic valve thrombosis may occur years after valve replacement; therefore, any deterioration in a patient's clinical status (new-onset dyspnea, heart failure or atrial fibrillation) warrants a thorough evaluation of the bioprosthetic valve with transesophageal echocardiography. In this case, initiation of anticoagulation obviated the need for redo mitral valve replacement. Figure 1(A) Mid-esophageal 2-chamber TEE image reveals a massive left atrial mural thrombus (yellow arrow) and markedly thickened bioprosthetic mitral leaflets (white arrow). (B) Mid-esophageal long-axis TEE image reveals a massive left atrial mural thrombus (yellow arrow) and markedly thickened bioprosthetic mitral leaflets (white arrow). (C) Off-axis TEE view of the left atrium reveals a massive left atrial thrombus (white arrow). (D) Three-dimensional en face view (left atrial perspective) of the stenotic bioprosthetic mitral valve. Note the left atrial mural thrombus (black arrow). Figure 2(A) Intraoperative mid-esophageal 2-chamber TEE image demonstrates thin and pliable bioprosthetic mitral leaflets (white arrow) after 5 days of intravenous heparin (compare to [Fig. 1A](#fig1){ref-type="fig"} and [B](#fig1){ref-type="fig"}). The left atrial thrombus remains (yellow arrow). (B) Intraoperative mid-esophageal TEE image after extraction of the left atrial thrombus (compare to [Fig. 2A](#fig2){ref-type="fig"}). The bioprosthetic mitral leaflets appear normal (white arrow). (C) Three-dimensional en face view (left atrial perspective). The mitral valve area is improved (compared to [Fig. 1D](#fig1){ref-type="fig"}), and the left atrial thrombus has been extracted. (D) Left atrial thrombus after resection. Video 1Mid-esophageal 2-chamber TEE image reveals a massive left atrial mural thrombus and markedly thickened bioprosthetic mitral leaflets. View Video 1 at <http://movie-usa.glencoesoftware.com/video/10.1530/ERP-17-0004/video-1>.Download Video 1 Video 2Mid-esophageal long axis TEE image reveals a massive left atrial mural thrombus and markedly thickened bioprosthetic mitral leaflets. View Video 2 at <http://movie-usa.glencoesoftware.com/video/10.1530/ERP-17-0004/video-2>.Download Video 2 Video 3Off-axis TEE view of the left atrium reveals a massive left atrial thrombus. View Video 3 at <http://movie-usa.glencoesoftware.com/video/10.1530/ERP-17-0004/video-3>.Download Video 3 Video 4Three-dimensional en face view (left atrial perspective) of the stenotic bioprosthetic mitral valve. Note the left atrial mural thrombus. View Video 4 at <http://movie-usa.glencoesoftware.com/video/10.1530/ERP-17-0004/video-4>.Download Video 4 Video 5Intraoperative mid-esophageal 2-chamber TEE image demonstrates thin and pliable bioprosthetic mitral leaflets after 5 days of intravenous heparin (compare to [Fig. 1A](#fig1){ref-type="fig"} and [B](#fig1){ref-type="fig"}). The left atrial thrombus remains. View Video 5 at <http://movie-usa.glencoesoftware.com/video/10.1530/ERP-17-0004/video-5>.Download Video 5 Video 6Intraoperative mid-esophageal TEE image after extraction of the left atrial thrombus (compare to [Fig. 2A](#fig2){ref-type="fig"}). The bioprosthetic mitral leaflets appear normal. View Video 6 at <http://movie-usa.glencoesoftware.com/video/10.1530/ERP-17-0004/video-6>.Download Video 6 Video 7Three-dimensional en face view (left atrial perspective). The mitral valve area is improved (compared to [Fig. 1D](#fig1){ref-type="fig"}), and the left atrial thrombus has been extracted. View Video 7 at <http://movie-usa.glencoesoftware.com/video/10.1530/ERP-17-0004/video-7>.Download Video 7
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